Astrazeneca said that the pause was “a routine action” while the volunteer’s illness was investigatedA large trial of the candidate coronavirus vaccine developed by Oxford University has been put on hold in the United States after a volunteer suffered a possible serious adverse reaction. A spokeswoman for Astrazeneca, the British drugmaker that is partnering with Oxford University, told The Times in a statement: “As part of the ongoing randomised, controlled global trials of the Oxford coronavirus vaccine, our standard review process was triggered and we voluntarily paused vaccination to allow review of safety data by an independent committee. “This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials. In large trials illnesses will happen by chance

Source: The Times September 09, 2020 00:39 UTC